Immunovia AB (publ) (1YR) Stock Price & News

All values in SEK	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	101.00K	354.00K	374.00K	381.00K
Cost of goods sold	36.00K	100.00K	143.00K	242.00K
Cost of revenue	36.00K	100.00K	143.00K	242.00K
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	24.67M	15.86M	17.88M	22.29M
Operating expense	25.12M	16.63M	18.72M	23.04M
Total operating expenses	25.15M	16.73M	18.86M	23.28M
Operating income	-25.05M	-16.38M	-18.48M	-22.90M
Other non operating income	1.00K	-69.00K	50.00K	25.00K
EBT including unusual items	-29.74M	-17.33M	-18.43M	-22.83M
EBT excluding unusual items	-29.74M	-17.33M	-18.43M	-22.83M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	93.00K	816.00K	11.00K
Net income	-29.74M	-17.33M	-18.43M	-22.83M
Net profit margin	-29,449.50%	-4,895.20%	-4,928.88%	-5,991.86%
Earnings per share	-10.00	-0.03	-0.03	-0.03
Interest and investment income	11.00K	63.08M	-	49.00K
Interest expense	-4.70M	-	-	-
Net interest expenses	-4.69M	63.08M	-	49.00K
Depreciation and amortization charges	450.00K	674.00K	17.00K	738.00K
EBITDA	-24.60M	-15.70M	-18.47M	-22.16M
Gain or loss from assets sale	-	-	-	-

Finance